Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Market share
The proportion of an individual company's sales compared to total sales from all companies for a product in a given market. This is usually expressed as a percentage.
Marketers require translation of sales targets into market share as it demonstrates whether forecasts are to be achieved by expanding with the market or by capturing shares from rival businesses. Market share is closely scrutinised for evidence of change in this aggressive environment, and it generally activates strategic or tactical action.
See also:
Market forecast
Market leader
Market positioning
Market segmentation
Related terms
Marketing concept, Market leader, Market entry, Horizon scanning, Territory, Learning curve, Maturation, Test marketing, Marketing orientation, Marketing mix, Ad rotation, Four Ps, Peer to peer (P2P) marketing, Marketing metrics, Oligopsony,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
- BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System
- BMS and 2seventy bio move away from CAR-T programme
- Live Webinar: Measuring Vital Health Indicators Through Your Camera
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role
- Live Webinar: Expanding Access to High-Quality Healthcare
- Vir Biotech launches new research programme for HIV and malaria prevention
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Why pharma must get smart in its approach to customer engagement
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- AstraZeneca's Enhertu receives FDA grant for priority review
- J&J’s COVID-19 booster shows 85% effectiveness in preventing hospitalisation for COVID-19 in study
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
